OBJECTIVES: Little is known about the relation between cytokine profile at birth and acute lower respiratory illnesses in the first year of life. The purpose of this work was to examine the relation between cytokine secretions by cord blood mononuclear cells and acute lower respiratory illness in a birth cohort of 297 children. METHODS: Cord blood mononuclear cells were isolated, and secretion of interferon-gamma, interleukin-13, interleukin-10, and tumor necrosis factor-alpha at baseline and in response to allergens (Blatella germanica 2 and Dermatophagoides farinae 1) and mitogen (phytohemagglutinin) were quantified using enzyme-linked immunosorbent assay. Acute lower respiratory illness was defined as a parental report of a diagnosis of bronchiolitis, pneumonia, bronchitis, and/or croup by a health care professional in the first year of life. Differences in the levels of cord blood cytokines between children with and without acute lower respiratory illness were examined using 2-sample Wilcoxon tests. Logistic regression models were used to examine the relation between various categories of cord blood cytokines and acute lower respiratory illness. RESULTS: Median levels of interferon-gamma secreted by cord blood mononuclear cells in response to Blatella germanica 2 and Dermatophagoides farinae 1 were higher among children without acute lower respiratory illness as compared with children with acute lower respiratory illness. After adjustment for other covariates, the odds of acute lower respiratory illness was reduced among children in the top category (at or more than the median of detectable values) of interferon-gamma level, significantly so in response to Blatella germanica 2. CONCLUSIONS: In a cohort of children from the general population, we found that upregulated interferon-gamma secretion at birth is associated with reduced risk of acute lower respiratory illness in the first year of life.
OBJECTIVES: Little is known about the relation between cytokine profile at birth and acute lower respiratory illnesses in the first year of life. The purpose of this work was to examine the relation between cytokine secretions by cord blood mononuclear cells and acute lower respiratory illness in a birth cohort of 297 children. METHODS: Cord blood mononuclear cells were isolated, and secretion of interferon-gamma, interleukin-13, interleukin-10, and tumor necrosis factor-alpha at baseline and in response to allergens (Blatella germanica 2 and Dermatophagoides farinae 1) and mitogen (phytohemagglutinin) were quantified using enzyme-linked immunosorbent assay. Acute lower respiratory illness was defined as a parental report of a diagnosis of bronchiolitis, pneumonia, bronchitis, and/or croup by a health care professional in the first year of life. Differences in the levels of cord blood cytokines between children with and without acute lower respiratory illness were examined using 2-sample Wilcoxon tests. Logistic regression models were used to examine the relation between various categories of cord blood cytokines and acute lower respiratory illness. RESULTS: Median levels of interferon-gamma secreted by cord blood mononuclear cells in response to Blatella germanica 2 and Dermatophagoides farinae 1 were higher among children without acute lower respiratory illness as compared with children with acute lower respiratory illness. After adjustment for other covariates, the odds of acute lower respiratory illness was reduced among children in the top category (at or more than the median of detectable values) of interferon-gamma level, significantly so in response to Blatella germanica 2. CONCLUSIONS: In a cohort of children from the general population, we found that upregulated interferon-gamma secretion at birth is associated with reduced risk of acute lower respiratory illness in the first year of life.
Authors: L Bont; C J Heijnen; A Kavelaars; W M van Aalderen; F Brus; J M Draaisma; M Pekelharing-Berghuis; R A van Diemen-Steenvoorde; J L Kimpen Journal: J Infect Dis Date: 2001-06-26 Impact factor: 5.226
Authors: Robert F Lemanske; Daniel J Jackson; Ronald E Gangnon; Michael D Evans; Zhanhai Li; Peter A Shult; Carol J Kirk; Erik Reisdorf; Kathy A Roberg; Elizabeth L Anderson; Kirstin T Carlson-Dakes; Kiva J Adler; Stephanie Gilbertson-White; Tressa E Pappas; Douglas F Dasilva; Christopher J Tisler; James E Gern Journal: J Allergy Clin Immunol Date: 2005-09 Impact factor: 10.793
Authors: J H Aberle; S W Aberle; M N Dworzak; C W Mandl; W Rebhandl; G Vollnhofer; M Kundi; T Popow-Kraupp Journal: Am J Respir Crit Care Med Date: 1999-10 Impact factor: 21.405
Authors: Megan L Krause; John M Davis; Keith L Knutson; Michael A Strausbauch; Michael A Strausbach; Cynthia S Crowson; Terry M Therneau; Peter J Wettstein; Eric L Matteson; Sherine E Gabriel Journal: Clin Immunol Date: 2011-05-30 Impact factor: 3.969
Authors: Jill Hahn; Diane R Gold; Brent A Coull; Marie C McCormick; Patricia W Finn; David L Perkins; Janet W Rich-Edwards; Sheryl L Rifas Shiman; Emily Oken; Laura D Kubzansky Journal: Psychosom Med Date: 2019-05 Impact factor: 4.312
Authors: Diane R Gold; Gordon R Bloomberg; William W Cruikshank; Cynthia M Visness; John Schwarz; Meyer Kattan; George T O'Connor; Robert A Wood; Melissa S Burger; Rosalind J Wright; Frank Witter; Aviva Lee-Parritz; Rhoda Sperling; Yoel Sadovsky; Alkis Togias; James E Gern Journal: J Allergy Clin Immunol Date: 2009-11 Impact factor: 10.793
Authors: Cynthia Lendor; Alina Johnson; Matthew Perzanowski; Ginger L Chew; Inge F Goldstein; Elizabeth Kelvin; Frederica Perera; Rachel L Miller Journal: Ann Allergy Asthma Immunol Date: 2008-08 Impact factor: 6.347
Authors: Philipp Latzin; Urs Frey; Jakob Armann; Elisabeth Kieninger; Oliver Fuchs; Martin Röösli; Bianca Schaub Journal: PLoS One Date: 2011-08-03 Impact factor: 3.240
Authors: Kaharu Sumino; Jennifer Tucker; Muhammad Shahab; Katy F Jaffee; Cynthia M Visness; James E Gern; Gordon R Bloomberg; Michael J Holtzman Journal: J Allergy Clin Immunol Date: 2012-03-27 Impact factor: 10.793
Authors: Matthew C Altman; Avraham Beigelman; Christina Ciaccio; James E Gern; Peter W Heymann; Daniel J Jackson; Joshua L Kennedy; Kirsten Kloepfer; Robert F Lemanske; Laurie M McWilliams; Lyndsey Muehling; Christy Nance; R Stokes Peebles Journal: J Allergy Clin Immunol Date: 2020-01-09 Impact factor: 14.290
Authors: Jill Hahn; Diane R Gold; Brent A Coull; Marie C McCormick; Patricia W Finn; David L Perkins; Sheryl L Rifas Shiman; Emily Oken; Laura D Kubzansky Journal: Int J Environ Res Public Health Date: 2021-05-11 Impact factor: 3.390